Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype

IEEE Transactions on Medical Imaging

Volumn 28, Issue 6, 2009, Pages 861-871

  Cao, Minsong ^a,b   Liang, Yun ^b   Shen, Changyu ^c   Miller, Kathy D ^b   Stantz, Keith M ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Indian University   (United States)

Author keywords

Breast cancer; Compartmental model; Dynamic contrast enhanced computed tomography (DCE CT); Tumor heterogeneity; Vascular endothelium growth factor (VEGF)

Indexed keywords

BREAST CANCER; COMPARTMENTAL MODEL; DYNAMIC CONTRAST ENHANCED COMPUTED TOMOGRAPHY (DCE-CT); TUMOR HETEROGENEITY; VASCULAR ENDOTHELIUM GROWTH FACTOR (VEGF);

BIOACTIVITY; BLOOD VESSELS; BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; CURVE FITTING; MUSCLE; ONCOLOGY; PEPTIDES; PHYSIOLOGY; POSITRON ANNIHILATION SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; SIZE DISTRIBUTION; TUMORS;

PHYSIOLOGICAL MODELS;

CONTRAST MEDIUM; IOPAMIDOL;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BREAST TUMOR; CANCER TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOCHEMISTRY; DISEASE MODEL; FEMALE; HUMAN; IMAGE PROCESSING; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; NUDE MOUSE; PATHOLOGY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REPRODUCIBILITY; XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMALS; BREAST NEOPLASMS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IOPAMIDOL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HETEROLOGOUS;

EID: 66249147239     PISSN: 02780062     EISSN: None     Source Type: Journal    
DOI: 10.1109/TMI.2008.2012035     Document Type: Article

References (55)

1. P. Carmeliet and R. K. Jain, "Angiogenesis in cancer and other diseases," Nature, vol. 407, pp. 249-257, 2000.
2. M. J. Cross, J. Dixelius, T. Matsumoto, and L. Claesson-Welsh, "VEGF-receptor signal transduction," Trends Biochem. Sci., vol. 28, pp. 488-494, 2003.
3. G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, "Vascular-specific growth factors and blood vessel formation," Nature, vol. 407, pp. 242-248, 2000.
4. P. W. Vaupel, "The influence of tumor blood flow and microenviron-mental factors on the efficacy of radiation, drugs and localized hyper-thermia," Klin Padiatr., vol. 209, pp. 243-249, 1997.
5. K. D. Miller, "Issues and challenges for antiangiogenic therapies," Breast Cancer Res. Treat., vol. 75, no. Suppl 1, pp. S45-S50, 2002.
6. R. K. Jain, "Molecular regulation of vessel maturation," Nat. Med., vol. 9, pp. 685-693, 2003.
7. B. S. Kuszyk, F. M. Corl, F. N. Franano, D. A. Bluemke, L. V. Hof-mann, B. J. Fortman, and E. K. Fishman, "Tumor transport physiology: Implications for imaging and imaging-guided therapy," AJR Am. J. Roentgenol., vol. 177, pp. 747-753, 2001.
8. R. K. Jain, "1995 Whitaker lecture: Delivery of molecules, particles, and cells to solid tumors," Ann. Biomed. Eng., vol. 24, pp. 457-473, 1996.
9. G. Gasparini, R. Longo, M. Fanelli, and B. A. Teicher, "Combination of antiangiogenic therapy with other anticancer therapies: Results, challenges, and open questions," J. Clin. Oncol, vol. 23, pp. 1295-1311, 2005.
10. R. Murata, Y. Nishimura, and M. Hiraoka, "An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma," Int. J. Radiat. Oncol. Biol. Phys., vol. 37, pp. 1107-1113, 1997.
11. B. M. Fenton, S. F. Paoni, and I. Ding, "Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumors," Radiother. Oncol., vol. 72, pp. 221-230, 2004.
12. F. Winkler, S. V. Kozin, R. T. Tong, S. S. Chae, M. F. Booth, I. Garkavtsev, L. Xu, D. J. Hicklin, D. Fukumura, T. E. di, L. L. Munn, and R. K. Jain, "Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases," Cancer Cell, vol. 6, pp. 553-563, 2004.
13. H. Wildiers, G. Guetens, B. G. De, E. Verbeken, B. Landuyt, W. Lan-duyt, E. A. De Bruijn, and A. T. Van Oosterom, "Effect of antivas-cular endothelial growth factor treatment on the intratumoral uptake of CPT-11," Br. J. Cancer, vol. 88, pp. 1979-1986, 2003.
14. K. Pietras, M. Stumm, M. Hubert, E. Buchdunger, K. Rubin, C. H. Heldin, P. McSheehy, M. Wartmann, and A. Ostman, "STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake," Clin. Cancer Res., vol. 9, pp. 3779-3787, 2003.
15. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, N. Ferrara, G. Fyfe, B. Rogers, R. Ross, and F. Kabbinavar, "Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer," New Eng. J. Med., vol. 350, pp. 2335-2342, 2004.
16. R. K. Jain, "Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy," Nat. Med., vol. 7, pp. 987-989, 2001.
17. R. K. Jain, "Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy," Science, vol. 307, pp. 58-62, 2005.
18. P. L. Choyke, M. V. Knopp, and S. K. Libutti, "Special techniques for imaging blood flow to tumors," Cancer J., vol. 8, pp. 109-118, 2002.
19. P. L. Choyke, A. J. Dwyer, and M. V. Knopp, "Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging," J. Magn. Reson. Imag., vol. 17, pp. 509-520, 2003.
20. L. Bogin, R. Margalit, J. Mispelter, and H. Degani, "Parametric imaging of tumor perfusion using flow- and permeability-limited tracers," J. Magn. Reson. Imag., vol. 16, pp. 289-299, 2002.
21. D. Checkley, J. J. Tessier, J. Kendrew, J. C. Waterton, and S. R. Wedge, "Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours," Br. J. Cancer, vol. 89, pp. 1889-1895, 2003.
22. B. A. Graff, I. C. Benjaminsen, K. G. Brurberg, E. B. Ruud, and E. K. Rofstad, "Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging," J. Magn. Reson. Imag., vol. 21, pp. 272-281, 2005.
23. K. L. Li, L. J. Wilmes, R. G. Henry, M. G. Pallavicini, J. W. Park, D. D. Hu-Lowe, T. M. McShane, D. R. Shalinsky, Y. J. Fu, R. C. Brasch, and N. M. Hylton, "Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: Assessment by voxel analysis of dynamic contrast-enhanced MRI," J. Magn. Reson. Imag., vol. 22, pp. 511-519, 2005.
24. G. Brix, M. L. Bahner, U. Hoffmann, A. Horvath, and W. Schreiber, "Regional blood flow, capillary permeability, and compartmental volumes: Measurement with dynamic CT - Initial experience," Radiology, vol. 210, pp. 269-276, 1999.
25. L. M. Hamberg, P. E. Kristjansen, G. J. Hunter, G. L. Wolf, and R. K. Jain, "Spatial heterogeneity in tumor perfusion measured with functional computed tomography at 0.05 microliter resolution," Cancer Res., vol. 54, pp. 6032-6036, 1994.
26. Z. Kan, S. Phongkitkarun, S. Kobayashi, Y. Tang, L. M. Ellis, T. Y. Lee, and C. Charnsangavej, "Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model," Radiology, vol. 237, pp. 151-158, 2005.
27. G. Krishnamurthi, K. M. Stantz, R. Steinmetz, V. H. Gattone, M. S. Cao, G. D. Hutchins, and Y. Liang, "Functional imaging in small animals using X-ray computed tomography - Study of physiologic measurement reproducibility," IEEE Trans. Med. Imag., vol. 24, no. 7, pp. 832-843, Jul. 2005.
28. K. M. Stantz, L. Yun, L. Xiong, K. Chingai, and R. Steinmetz, "Imaging the progression of intra-tumor heterogeneity in prostate and ovarian xenografts using dynamic contrast-enhanced CT," in Proc. 27th Annu. Int. Conf. Eng. Med. Biol. Soc, 2005, pp. 1883-1886.
29. R. E. Pollard, T. C. Garcia, S. M. Stieger, K. W. Ferrara, A. R. Sad-lowski, and E. R. Wisner, "Quantitative evaluation of perfusion and permeability of peripheral tumors using contrast-enhanced computed tomography," Invest Radial., vol. 39, pp. 340-349, 2004.
30. K. M. Stantz, Y. Liang, and G. D. Hutchins, "Kinematic modeling and its implication in longitudinal chemotherapy study of tumor physiology: Ovarian xenograft mouse model and contrast-enhanced dynamic CT," in Proc. SPIE Med. Imag. 2004: Physiol., Function, Structure Med. Images, San Diego, CA, 2004, vol. 5369, pp. 769-779.
31. C. G. Crispens, Handbook on the Laboratory Mouse. Springfield, IL: Thomas, 1975.
32. K. D. Miller, M. Miller, S. Mehrotra, B. Agarwal, B. H. Mock, Q. H. Zheng, S. Badve, G. D. Hutchins, and G. W. Sledge, Jr., "A physiologic imaging pilot study of breast cancer treated with AZD2171," Clin. Cancer Res., vol. 12, pp. 281-288, 2006.
33. J. A. Sorenson and M. E. Phelps, Physics in Nuclear Medicine, 2nd ed. Orlando, FL: Grune & Stratton, 1987.
34. H. T. Zhang, P. Craft, P. A. Scott, M. Ziche, H. A. Weich, A. L. Harris, and R. Bicknell, "Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells," J. Nat. Cancer Inst., vol. 87, pp. 213-219, 1995.
35. P. Guo, Q. Fang, H. Q. Tao, C. A. Schafer, B. M. Fenton, I. Ding, B. Hu, and S. Y. Cheng, "Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo," Cancer Res., vol. 63, pp. 4684-4691, 2003.
36. F. Bolat, F. Kayaselcuk, T. Z. Nursal, M. C. Yagmurdur, N. Bal, and B. Demirhan, "Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: Correlations with prognostic parameters," J. Exp. Clin. Cancer Res., vol. 25, pp. 365-372, 2006.
37. R. A. Mohammed, A. Green, S. El-Shikh, E. C. Paish, I. O. Ellis, and S. G. Martin, "Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio-and lymphangiogenesis," Br. J. Cancer, vol. 96, pp. 1092-1100, 2007.
38. M. Lewin, S. Bredow, N. Sergeyev, E. Marecos, A. Bogdanov, Jr., and R. Weissleder, "In vivo assessment of vascular endothelial growth factor-induced angiogenesis," Int. J. Cancer, vol. 83, pp. 798-802, 1999.
39. J. V. Gaustad, I. C. Benjaminsen, B. A. Graff, K. G. Brurberg, E. B. Ruud, and E. K. Rofstad, "Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging," J. Magn. Reson. Imag., vol. 21, pp. 792-800, 2005.
40. B. A. Graff, I. C. Benjaminsen, E. A. Melas, K. G. Brurberg, and E. K. Rofstad, "Changes in intratumor heterogeneity in blood perfusion in in-tradermal human melanoma xenografts during tumor growth assessed by DCE-MRI," Magn. Reson. Imag., vol. 23, pp. 961-966, 2005.
41. I. C. Benjaminsen, B. A. Graff, K. G. Brurberg, and E. K. Rofstad, "Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts,"Magn. Reson. Med., vol. 52, pp. 269-276, 2004.
42. E. Furman-Haran, R. Margalit, D. Grobgeld, and H. Degani, "Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors," Proc. Nat. Acad. Sci. USA, vol. 93, pp. 6247-6251, 1996.
43. Y. Okuhata, R. C. Brasch, C. D. Pham, H. Daldrup, M. F. Wendland, D. M. Shames, and T. P. Roberts, "Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: Regional heterogeneity and postmortem artifacts," J. Magn. Reson. Imag., vol. 9, pp. 685-690, 1999.
44. S. Makkat, R. Luypaert, S. Sourbron, T. Stadnik, and M. J. De, "Quantification of perfusion and permeability in breast tumors with a de-convolution-based analysis of second-bolus T1-DCE data," J. Magn. Reson. Imag., vol. 25, pp. 1159-1167, 2007.
45. Y. Sugawara, K. Murase, K. Kikuchi, K. Sakayama, T. Miyazaki, M. Kajihara, H. Miki, and T. Mochizuki, "Measurement of tumor blood flow using dynamic contrast-enhanced magnetic resonance imaging and deconvolution analysis: A preliminary study in musculoskeletal tumors," J. Comput. Assist. Tomogr., vol. 30, pp. 983-990, 2006.
46. N. A. Mayr, W. T. Yuh, J. C. Arnholt, J. C. Ehrhardt, J. I. Sorosky, V. A. Magnotta, K. S. Berbaum, W. Zhen, A. C. Paulino, L. W. Oberley, A. K. Sood, and J. M. Buatti, "Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer," J. Magn. Reson. Imag., vol. 12, pp. 1027-1033, 2000.
47. S. S. Kety, "The theory and applications of the exchange of inert gas at the lungs and tissues," Pharmacol. Rev., vol. 3, pp. 1-41, 1951.
48. P. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. V. Knopp, H. B. Larsson, T. Y. Lee, N. A. Mayr, G. J. Parker, R. E. Port, J. Taylor, and R. M. Weisskoff, "Estimating kinetic parameters from dynamic contrast-enhanced T(l)-weighted MRI of a diffusable tracer: Standardized quantities and symbols," J. Magn. Reson. Imag., vol. 10, pp. 223-232, 1999.
49. M. Morales and R. Smith, "On the theory of blood-tissue exchange of inert gas. VI. Validity of approximate uptake expression," Bull. Math. Biophys., vol. 10, pp. 191-200, 1948.
50. M. Heilmann, F. Kiessling, M. Enderlin, and L. R. Schad, "Determination of pharmacokinetic parameters in DCE MRI: Consequence of nonlinearity between contrast agent concentration and signal intensity," Invest. Radiol, vol. 41, pp. 536-543, 2006.
51. C. A. Mistretta, O. Wieben, J. Velikina, W. Block, J. Perry, and Y. Wu, "Highly constrained backprojection for time-resovled MRI," Magn. Reson. Med., vol. 55, no. 1, pp. 30-40, 2006.
52. B. Liu, R. Kruger, D. R. Reinecke, and K. M. Stantz, "Determination of blood oxygen saturation by PCT small animal scanner," in Acad. Molecular Imag. Annu. Conf. Mol. Imag. Biol., Orlando, FL, 2006, vol. 8, no. 2, p. 92.
53. K. M. Stantz, B. Liu, M. Cao, D. R. Reinecke, M. Dzemidzic, Y. Liang, and R. A. Kruger, "Measuring hypoxic factors in solid tumors using photoacoustic and x-ray CT," Molecular Imag., vol. 5, no. 2, pp. 362-3, 2006.
54. K. M. Stantz, Y. Liang, B. Liu, M. Cao, D. R. Reinecke, and R. Kruger, "Evaluating dynamic contrast-enhanced and photoacoustic CT to assess intra-tumor heterogeneity in wild-type and VEGF enhanced MCF-7 breast tumors," SPIE. Medical Imaging 2005: Physiology, Function, and Structure from Medical Images, 2006.
55. K. M. Stantz, B. Liu, M. Cao, D. R. Reinecke, K. D. Miller, and R. Kruger, "Photoacoustic spectroscopic imaging of intra-tumor heterogeneity and molecular identification," in Proc. SPIE BIOS, 2006, vol. 6086, pp. 36-47.